References
- KontaxakisVPSkouridesDFerentinosPHavaki-KontaxakiBJPapadimitriouGNIsotretinoin and psychopathology: A reviewAnn Gen Psychiatry20098219154613
- StrahanJERaimerSIsotretinoin and the controversy of psychiatric adverse effectsInt J Dermatol200645778979916863513
- SchafferLCSchafferCBHunterSMillerAPsychiatric reactions to isotretinoin in patients with bipolar disorderJ Affect Disord2010122330630819783054
- SheehanDVLecrubierYSheehanKHThe Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10J Clin Psychiatry199859Suppl 2022339881538
- MoritzSMeierBKlossMDimensional structure of the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS)Psychiatry Res2002109219319911927144
- YoungRCBiggsJTZieglerVEMeyerDAA rating scale for mania: Reliability, validity and sensitivityBr J Psychiatry1978133429435728692
- FornaroMGabrielliFAlbanoCObsessive-compulsive disorder and related disorders: A comprehensive surveyAnn Gen Psychiatry200981319450269
- BrosigBKupferJNiemeierVGielerUThe “Dorian Gray Syndrome”: Psychodynamic need for hair growth restorers and other “fountains of youth”Int J Clin Pharmacol Ther200139727928311471770
- GuptaMAGuptaAKDepression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasisBr J Dermatol199813958468509892952
- SchafferLCSchafferCBHunterSMillerAPsychiatric reactions to isotretinoin in patients with bipolar disorderJ Affect Disord2010122330630819783054
- CottADWisnerKLIsotretinoin treatment of a woman with bipolar disorderJ Clin Psychiatry199960640740810401921
- van BroekhovenFVerkesRJJanzingJGPsychiatric symptoms during isotretinoin therapyNed Tijdschr Geneeskd20031474723412343 Dutch14669543
- BarakYWohlYGreenbergYAffective psychosis following Accutane (isotretinoin) treatmentInt Clin Psychopharmacol2005201394115602115
- BremnerJDMcCafferyPThe neurobiology of retinoic acid in affective disordersProg Neuropsychopharmacol Biol Psychiatry200832231533117707566
- LeonardBESigma receptors and sigma ligands: Background to a pharmacological enigmaPharmacopsychiatry200437Suppl 3S16617015547782
- CobosEJEntrenaJMNietoFRCendánCMDel PozoEPharmacology and therapeutic potential of sigma(1) receptor ligandsCurr Neuropharmacol20086434436619587856
- StahlSMThe sigma enigma: Can sigma receptors provide a novel target for disorders of mood and cognition?J Clin Psychiatry200869111673167419200426
- StahlSMAntidepressant treatment of psychotic major depression: Potential role of the sigma receptorCNS Spectr200510431932315788959
- BogettoFBellinoSVaschettoPZieroSOlanzapine augmentation of fluvoxamine-refractory obsessive-compulsive disorder (OCD): A 12-week open trialPsychiatry Res2000962919811063782
- MarazzitiDPfannerCDell’OssoBAugmentation strategy with olanzapine in resistant obsessive compulsive disorder: An Italian long-term open-label studyJ Psychopharmacol200519439239415982994
- FornaroMGabrielliFMatteiCVinciguerraVFornaroPAripiprazole augmentation in poor insight obsessive-compulsive disorder: A case reportAnn Gen Psychiatry200872619105842
- RamasubbuRARavindranALapierreYSerotonin and dopamine antagonism in obsessive-compulsive disorder: Effect of atypical antipsychotic drugsPharmacopsychiatry200033623623811147933
- GrunzeHVietaEGoodwinGMThe World Federation of Societies of Biological Psychiatry (WFSBP)Guidelines for the biological treatment of bipolar disorders: Update 2010 on the treatment of acute bipolar depressionWorld J Biol Psychiatry20101128110920148751
- AkiskalHSBenazziFValidating Kraepelin’s two types of depressive mixed states: “Depression with flight of ideas” and “excited depression”World J Biol Psychiatry20045210711315179670
- MatsuzakiHIzumiTHorinouchiTJuvenile stress attenuates the dorsal hippocampal postsynaptic 5-HT(1A) receptor function in adult ratsPsychopharmacology (Berl)2010817 [Epub ahead of print]